Article
HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
1 Jan 2016
Abstract excerpt
Histone deacetylases (HDACs) are epigenetic regulators that regulate the histone tail, chromatin conformation, protein-DNA interaction, and even transcription. HDACs are also post-transcriptional modifiers that regulate the protein acetylation implicated in several pathophysiologic states. HDAC inhibitors have been highlighted as a novel category of anti-cancer drugs. To date, four HDAC inhibitors, Vorinostat,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
